About Noul Co., Ltd.

Noul Co., Ltd. is a South Korean biotechnology company founded in 2015, specializing in AI-powered in vitro diagnostics and remote diagnosis solutions for infectious and non-infectious diseases. The company's flagship miLab™ platform is an advanced digital diagnostic system that automates blood analysis, sample preparation, and AI-driven pathology…

Read full company overview

Noul Co., Ltd. is a South Korean biotechnology company founded in 2015, specializing in AI-powered in vitro diagnostics and remote diagnosis solutions for infectious and non-infectious diseases. The company's flagship miLab™ platform is an advanced digital diagnostic system that automates blood analysis, sample preparation, and AI-driven pathology interpretation. Noul's product portfolio addresses critical global healthcare challenges, focusing on malaria diagnosis, complete blood count (CBC) and cell morphology analysis, and early cervical cancer detection through AI-powered cytology. The company has established international partnerships and distribution agreements, with presence across multiple countries. Noul's technology delivers significant improvements in diagnostic accessibility, speed (>2x reduction in analysis time), and accuracy, with clinical validation demonstrating high sensitivity and specificity. The company is committed to scaling diagnostic innovation globally, with a vision to impact one billion lives by 2030 through timely, accessible diagnostics for resource-limited and developed healthcare settings.

Company information is compiled from public sources and may be out of date. It is not an endorsement or medical advice.

Products (5)

Other products · 05
  • —

    miLab™ MAL

    Advanced digital microscope and automated analysis system for malaria diagnosis, combining high-resolution scanning with AI analysis for rapid, accurate parasite detection.

    Request quote
  • —

    miLab™ BCM

    Automated complete blood count (CBC) and cell morphology analysis solution, capable of processing microsamples (5 μL) for point-of-care and laboratory hematology applications.

    Request quote
  • —

    miLab™ CER

    AI-powered digital cytology platform for cervical cancer screening and early detection, automating cell analysis and risk stratification from cervical samples.

    Request quote
  • —

    miLab Platform

    Integrated diagnostic platform combining digital microscopy, automated staining, scanning, and AI analysis across blood and tissue diagnostics applications.

    Request quote
  • —

    Remote Diagnosis Services

    Telemedicine-enabled diagnostic consultation and reporting services leveraging miLab™ technology for distributed healthcare delivery.

    Request quote

Contact Information

www.noul.com
+82 31-308-6310
Yongin-si, Gyeonggi-do, South Korea, 448-130

Send an Enquiry

This supplier isn't receiving enquiries through MedIndexer yet. Contact via phone or website where available.

Need a structured price?

Submit an RFP to compare Noul Co., Ltd. alongside up to 4 other vendors. Sealed responses, side-by-side at the deadline.

Submit an RFP